HeyJaredOmor Ibne Ehsan
- Indexed articles, last 90 days
- 567
- Latest publication
- Oct 1, 2026
- Outlet visibility, for 247wallst.com
- Top 50K sites
- Earliest in this view
- Jul 6, 2026
Latest articles
Bank of America Cut Its Fair Isaac Price Target in Half and the Stock Still Fell Below It - AOL (opens the original)
Read excerpt
Bank of America halved FICO's price target to $700 from $1,400 and downgraded to Neutral, yet shares still dropped to $593. Rocket Mortgage named VantageScore its preferred model after regulators removed the 20-point pricing penalty that had shielded FICO's mortgage dominance. FICO borrowed $1.5 billion to buy back shares at $1,149 average and now carries $5.58 billion in debt with the stock near $593. Read More: Learn 7 ways to generate income with a $1,000,000+ portfolio (sponsor) Fair Isaac (
Bank of America Cut Its Fair Isaac Price Target in Half and the Stock Still Fell Below It (opens the original)
Read excerpt
Bank of America slashed its Fair Isaac price target by half, yet the stock kept falling right through it. What regulators just changed about mortgage credit scoring may have permanently altered the case for owning FICO. This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Fair Isaac (NYSE:FICO | FICO Price Prediction) slid below $600 in its latest session, closing at $592.52 after Bank of America (NYSE:BAC)
United Therapeutics Won Its Patent War and Liquidia Collapsed (opens the original)
Read excerpt
A single court ruling sent one pulmonary hypertension drugmaker soaring and left its rival fighting for survival, but the legal battle over Yutrepia's future is far from settled. This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. A Delaware court ruling on Wednesday pushed two pulmonary hypertension drugmakers in opposite directions. Pulmonary hypertension associated with interstitial lung disease (PH-ILD
United Therapeutics Won Its Patent War and Liquidia Collapsed - AOL (opens the original)
Read excerpt
UTHR surged 13% and LQDA collapsed 57%, erasing $3 billion in market value, after a court upheld a patent Liquidia had already admitted it infringed. Liquidia plans to appeal and seek FDA label removal, but Yutrepia drives nearly all its revenue while its pipeline candidate just began Phase 3 enrollment. If the court chooses royalties over an injunction, Yutrepia could remain on the market and blunt the competitive advantage United Therapeutics just won. Read More: Learn 7 ways to generate incom
Boeing Just Beat Northrop for a $20 Billion Navy Fighter Contract - AOL (opens the original)
Read excerpt
Boeing won a $20B Navy contract to develop the F/A-XX fighter, beating Northrop, whose stock dropped 4.2% while Boeing rose just 2% after hours. The deal covers only development and test jets, with no production contract yet in place, and Boeing's payoff remains years away at 50 times forward earnings. Northrop could still protest the award and holds a record $104B backlog with raised 2026 guidance, limiting damage from the loss. Building a portfolio and living off one are two completely differe
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For 247wallst.com, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.